Therapeutic anticoagulant therapy in patients with clinically unsuspected pulmonary embolism was associated with more frequent early deaths (7 vs 1; P=0.037) compared to no therapeutic ACT.
Cohort (n=1,966)
Does therapeutic anticoagulant therapy improve survival in patients with clinically unsuspected pulmonary embolism at chest CT?
Clinically unsuspected PE may remain undetected at routine chest CT, but these patients appear to have a favorable short-term outcome even without therapeutic anticoagulation.
p-value: p=0.037
PURPOSE: To retrospectively assess outcome in patients with clinically unsuspected pulmonary embolism (PE) at chest multi-detector row computed tomography (CT). MATERIALS AND METHODS: Institutional review board approval and informed consent were not required. PE was assessed in consecutive CT scans in 1966 patients (mean age, 60 years; range, 15-96 years; male-female ratio, 1.79) and graded with severity score. Studies with true-positive and false-negative radiologic diagnoses were determined. Coexisting morbidity, anticoagulant therapy (ACT), complications, and 1-year outcome were reviewed. Statistical evaluation included Mann-Whitney U test, chi(2) test, Poisson regression, and Kaplan-Meier statistics. RESULTS: Scans were PE positive in 117 patients. Clinical data review was complete in 96 patients; 63 of 96 patients had malignancy; in 58, PE was not suspected. In 38 of these 58 patients, radiology report findings were false-negative (mean severity score, 20.21 +/- 17.88 standard deviation and 9.55 +/- 7.12 for those with true-positive and false-negative findings, respectively; P = .012). Forty-nine patients received therapeutic ACT; 21, prophylactic ACT; and 26, no treatment. PE severity was higher in patients with therapeutic ACT versus those without (P 28, use of systemic thrombolytic therapy, occurrence of major hemorrhage, and new-onset cardiac or renal failure (P = .001-.043). Negative predictors were report with false-negative findings and no therapeutic ACT (P = .007-.037). Predictors of late death (n = 25) were older age, malignancy, and renal failure (P = .001-.043). CONCLUSION: Clinically unsuspected PE may remain undetected at routine chest CT; these patients have favorable short-term outcome without therapeutic ACT.
Engelke et al. (Mon,) conducted a cohort in Clinically unsuspected pulmonary embolism (n=1,966). Therapeutic anticoagulant therapy vs. No therapeutic anticoagulant therapy was evaluated on Early death (p=0.037). Therapeutic anticoagulant therapy in patients with clinically unsuspected pulmonary embolism was associated with more frequent early deaths (7 vs 1; P=0.037) compared to no therapeutic ACT.